Spectral Diagnostics Inc. (OTCMKTS:EDTXF – Get Free Report) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totaling 12,731 shares, an increase of 147.6% from the September 30th total of 5,142 shares. Based on an average trading volume of 8,964 shares, the days-to-cover ratio is presently 1.4 days. Currently, 0.0% of the company’s stock are sold short.
Spectral Diagnostics Price Performance
Shares of EDTXF stock traded up $0.06 on Friday, hitting $0.72. 1,235 shares of the stock traded hands, compared to its average volume of 10,148. The company has a market capitalization of $212.94 million, a PE ratio of -7.23 and a beta of 0.14. The company’s fifty day moving average is $0.84 and its 200 day moving average is $0.95. Spectral Diagnostics has a 1-year low of $0.64 and a 1-year high of $1.10.
About Spectral Diagnostics
Spectral Diagnostics Inc is a Canadian medical technology company focused on improving the diagnosis and treatment of sepsis and septic shock. The company develops products designed to identify endotoxin activity, an important factor in certain severe infections and inflammatory conditions.
Its principal diagnostic product is the Endotoxin Activity Assay, a blood test intended to measure a patient’s level of endotoxin activity and help identify individuals who may be at increased risk of developing severe sepsis.
Further Reading
- Five stocks we like better than Spectral Diagnostics
- Breaching the Valuation: The Real Reason Fortinet Dropped
- Microsoft Earnings Expose a Growing Divide in the Magnificent 7 AI Trade
- Silicon Shock: Intel’s 25% Valuation Reset
- Advanced Micro Devices’ Meta Platforms Partnership Goes Beyond a $1 Billion Investment
Receive News & Ratings for Spectral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
